The "United States Syringes, Needles and Urinary Catheters Market Outlook to 2033 - Needles, Syringes and Urinary Catheters" report has been added to ResearchAndMarkets.com's offering.The ...
Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B ...
The global safety needles market is poised for substantial growth, with the market’s value forecasted to rise from US$ 5,840.7 million in 2023 to an impressive US$ 11,972.7 million by 2033. This ...
Retractable manufactures and markets VanishPoint ® and Patient Safe ® safety medical products and the EasyPoint ® needle. The VanishPoint ® syringe, blood collection, and IV catheter products ...
StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP – Free Report) in a research note published on Monday. The firm issued a hold rating on the stock. Retractable ...
Researchers at the Indian Institute of Technology (IIT) Bombay have developed a shockwave-based needle-free syringe that ensures painless and safe drug delivery with lesser damage to the skin and ...
New Delhi: Researchers at the Indian Institute of Technology (IIT) Bombay have developed a shockwave-based needle-free syringe that ensures painless and safe drug delivery with lesser damage to the ...
Needles have played a crucial role in inducing life-saving vaccines, and drugs into a patient's system, however, when it's the most dreaded part of a child's experience at a doctor's clinic.